SG

Scott Gazelle

Director Emeritus at MGH Institute for Technology Assessment

Boston, Massachusetts

Overview

Work Experience

  • Attending Radiologist

    1992 - Current

  • Vice Chairman, Academic Advancement

    2018

  • Vice Chairman for Faculty Affairs

    2010 - 2018

    Developed and implemented programs that support recruitment, credentialing, maintenance of certification, career advancement, promotion and leadership development for >450 faculty members.

  • Associate Vice Chairman for Research

    2006 - 2018

    Overall responsibility for research finance and operations. The department has the largest radiology research program in the world, with approximately $100 million in annual research expenditures.

  • Director, Breast Imaging

    2013 - 2015

  • Founding Director, Institute for Technology Assessment

    1998 - 2015

    The ITA (www.mgh-ita.org) is one of the largest and most successful programs of its kind, with approximately 65 full-time faculty, staff and trainees and $30 million in active research funding. We conduct research to guide the development, evaluation and appropriate use of medical technologies and clinical programs that can improve the quality and cost-effectiveness of health care.

  • Associate Director, Center for Imaging and Pharmaceutical Research

    1992 - 1998

    Led efforts to develop blood-pool contrast agents for CT and ultrasound. Also established and led program to develop and evaluate equipment and techniques for radiofrequency tumor ablation.

  • Professor of Radiology

    2005

  • Professor in the Department of Health Policy and Management

    2006 - 2018

  • Founding Director

    2002 - 2018

    The Program in Cancer Outcomes Research Training is a multi-disciplinary training program that spans the hospitals and affiliated institutions of the Dana-Farber/Harvard Cancer Center. Its goal is to train leaders in cancer outcomes research.

  • Consultant

    2014 - 2015

  • Co-Founder and Co-Director

    1995 - 1999

    The CCTR was established to facilitate the involvement of researchers from the Brigham and Women's and Massachusetts General Hospitals in clinical trials of new imaging pharmaceuticals, devices and techniques.

Relevant Websites